Compare HMR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMR | XGN |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | Greece | United States |
| Employees | 52 | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.5M | 71.2M |
| IPO Year | N/A | 2014 |
| Metric | HMR | XGN |
|---|---|---|
| Price | $1.51 | $4.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $3.00 | ★ $8.86 |
| AVG Volume (30 Days) | 154.7K | ★ 481.3K |
| Earning Date | 06-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.04 | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $2.59 |
| 52 Week High | $2.15 | $12.23 |
| Indicator | HMR | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 82.05 | 67.79 |
| Support Level | $0.81 | $2.68 |
| Resistance Level | $1.55 | $6.75 |
| Average True Range (ATR) | 0.12 | 0.38 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 91.72 | 95.36 |
Heidmar Maritime Holdings Corp is a commercial and technical management company that operates tanker and dry-bulk vessel pools. The group, along with its subsidiaries, operates as a growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. Its lines of business currently include asset management, tanker pooling, commercial and time charters, assisting clients with the buying and selling of ships, and technical management services for individual vessels, which include assistance in technical operations and crewing of the vessel. Its geographic areas are Singapore, the USA, the Marshall Islands, the United Arab Emirates, Germany, Switzerland, and Other.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.